Patents by Inventor Rajeev Singh

Rajeev Singh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EXTENDED RELEASE DOSAGE FORMS OF QUETIAPINE
    Publication number: 20090220593
    Abstract: The present invention relates to multiple unit extended release dosage forms of quetiapine for oral administration, wherein each unit comprises a core containing quetiapine and one or more of pharmaceutically acceptable excipients coated with a rate-controlling coating and process for the preparation thereof.
    Type: Application
    Filed: January 28, 2009
    Publication date: September 3, 2009
    Inventors: Inder GULATI, Rajan Kumar Verma, Rajeev Singh Raghuvanshi
  • CARBAMAZEPINE FORMULATIONS
    Publication number: 20090143362
    Abstract: The present invention relates to a process for preparing a pharmaceutical composition comprising carbamazepine that has a constant release profile.
    Type: Application
    Filed: December 4, 2008
    Publication date: June 4, 2009
    Inventors: Umesh Vinayakrao BARABDE, Rajan Kumar Verma, Rajeev Singh Raghuvanshi
  • GALANTAMINE-CONTAINING CONTROLLED RELEASE ORAL DOSAGE FORMS, PROCESSES FOR THE PREPARATION THEREOF AND USE OF THE MANUFACTURE OF A MEDICAMENT
    Publication number: 20090087488
    Abstract: The present invention relates to controlled release oral dosage forms of galantamine or acceptable salts thereof and processes for the preparation thereof.
    Type: Application
    Filed: September 1, 2006
    Publication date: April 2, 2009
    Inventors: Rajan Kumar Verma, Narayanan Badri Viswanathan, Rajeev Singh Raghuvanshi, Ashok Rampal
  • Sustained release compositions containing alfuzosin
    Publication number: 20060147530
    Abstract: The present invention relates to pharmaceutical compositions of alfuzosin or pharmaceutically acceptable salt, solvate, enantiomers or mixtures thereof, that release the active ingredient over an extended period of time. The pharmaceutical composition can be a sustained release oral dosage form that includes a single functional layer and, optionally, one or more nonfunctional layers adjacent to the single functional layer. The single functional layer includes alfuzosin or pharmaceutically acceptable salt, solvate, enantiomers or mixtures thereof and one or more release retarding ingredients.
    Type: Application
    Filed: October 22, 2003
    Publication date: July 6, 2006
    Inventors: Narayanan Viswanathan, Sankar Ramakrishnan, Rajeev Singh Raghuvanshi, Ashok Rampal